ADX-102 Ophthalmic Solution (0.5%)
ADX-102-UV-005
Phase 3 small_molecule completed
Quick answer
ADX-102 Ophthalmic Solution (0.5%) for Non-infectious Anterior Uveitis is a Phase 3 program (small_molecule) at Aldeyra Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Aldeyra Therapeutics
- Indication
- Non-infectious Anterior Uveitis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed